Chemical Structure : Sorafenib
CAS No.: 284461-73-0
货号: PC-42445Not For Human Use, Lab Use Only.
Sorafenib (Bay 43-9006) is a potent, orally available Raf inhibitor with IC50 of 6, 22, and 38 nM for Raf-1, wt Braf, and BRaf V599E, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg (Free Sample) | ¥280 | In stock | |
100 mg | ¥780 | In stock | |
250 mg | ¥1280 | In stock | |
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Sorafenib (Bay 43-9006) is a potent, orally available Raf inhibitor with IC50 of 6, 22, and 38 nM for Raf-1, wt Braf, and BRaf V599E, respectively.
Sorafenib (Bay 43-9006) also demonstrates potent inhibition of certain proangiogenic RTKs, including VEGFR-2, PDGFR-β, VEGFR-3, Flt-3, c-Kit (IC50<100 nM).
Sorafenib (Bay 43-9006) exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.
分子量 | 464.825 | |
分子式 | C21H16ClF3N4O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 45 mg/mL |
|
Chemical Name/SMILES |
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl- |
1. Wilhelm SM, et al. Cancer Res. 2004 Oct 1;64(19):7099-109.
2. Carlomagno F, et al. J Natl Cancer Inst. 2006 Mar 1;98(5):326-34.
4. Lyons JF, et al. Endocr Relat Cancer. 2001 Sep;8(3):219-25.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright